+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Drugs Market Research Reports

From
From
From
From
From
Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 67 Pages
  • Global
From
Diabetes Drugs Companies in China - Product Thumbnail Image

Diabetes Drugs Companies in China

  • Report
  • August 2024
  • 76 Pages
  • China
From
From
Onglyza - API Insight, 2022 - Product Thumbnail Image

Onglyza - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Welchol - API Insight, 2022 - Product Thumbnail Image

Welchol - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Humalog - API Insight, 2022 - Product Thumbnail Image

Humalog - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin. Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more